These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 17974490

  • 1. Nabilone for the treatment of pain in fibromyalgia.
    Skrabek RQ, Galimova L, Ethans K, Perry D.
    J Pain; 2008 Feb; 9(2):164-73. PubMed ID: 17974490
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [Abstract] [Full Text] [Related]

  • 3. The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial.
    Ware MA, Fitzcharles MA, Joseph L, Shir Y.
    Anesth Analg; 2010 Feb 01; 110(2):604-10. PubMed ID: 20007734
    [Abstract] [Full Text] [Related]

  • 4. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
    Holman AJ, Myers RR.
    Arthritis Rheum; 2005 Aug 01; 52(8):2495-505. PubMed ID: 16052595
    [Abstract] [Full Text] [Related]

  • 5. Are cannabinoids a new treatment option for pain in patients with fibromyalgia?
    Staud R, Koo EB.
    Nat Clin Pract Rheumatol; 2008 Jul 01; 4(7):348-9. PubMed ID: 18521112
    [Abstract] [Full Text] [Related]

  • 6. An open-label comparison of nabilone and gabapentin as adjuvant therapy or monotherapy in the management of neuropathic pain in patients with peripheral neuropathy.
    Bestard JA, Toth CC.
    Pain Pract; 2011 Jul 01; 11(4):353-68. PubMed ID: 21087411
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Distler O, Eich W, Dokoupilova E, Dvorak Z, Fleck M, Gaubitz M, Hechler M, Jansen JP, Krause A, Bendszus M, Pache L, Reiter R, Müller-Ladner U.
    Arthritis Rheum; 2010 Jan 01; 62(1):291-300. PubMed ID: 20039417
    [Abstract] [Full Text] [Related]

  • 8. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.
    Gür A, Karakoc M, Nas K, Cevik R, Sarac J, Ataoglu S.
    Rheumatol Int; 2002 Sep 01; 22(5):188-93. PubMed ID: 12215864
    [Abstract] [Full Text] [Related]

  • 9. Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study.
    Frank B, Serpell MG, Hughes J, Matthews JN, Kapur D.
    BMJ; 2008 Jan 26; 336(7637):199-201. PubMed ID: 18182416
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of nabilone, a synthetic cannabinoid, on postoperative pain.
    Beaulieu P.
    Can J Anaesth; 2006 Aug 26; 53(8):769-75. PubMed ID: 16873343
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A randomized placebo-controlled study of noninvasive cortical electrostimulation in the treatment of fibromyalgia patients.
    Hargrove JB, Bennett RM, Simons DG, Smith SJ, Nagpal S, Deering DE.
    Pain Med; 2012 Jan 26; 13(1):115-24. PubMed ID: 22233397
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia.
    Arnold LM, Leon T, Whalen E, Barrett J.
    Psychosomatics; 2010 Jan 26; 51(6):489-97. PubMed ID: 21051680
    [Abstract] [Full Text] [Related]

  • 16. History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.
    Pae CU, Masand PS, Marks DM, Krulewicz S, Han C, Peindl K, Mannelli P, Patkar AA.
    World J Biol Psychiatry; 2009 Jan 26; 10(4 Pt 2):435-41. PubMed ID: 19382010
    [Abstract] [Full Text] [Related]

  • 17. Lack of effect of central nervous system-active doses of nabilone on capsaicin-induced pain and hyperalgesia.
    Kalliomäki J, Philipp A, Baxendale J, Annas P, Karlsten R, Segerdahl M.
    Clin Exp Pharmacol Physiol; 2012 Apr 26; 39(4):336-42. PubMed ID: 22233155
    [Abstract] [Full Text] [Related]

  • 18. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
    Younger J, Noor N, McCue R, Mackey S.
    Arthritis Rheum; 2013 Feb 26; 65(2):529-38. PubMed ID: 23359310
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
    Arnold LM, Zhang S, Pangallo BA.
    Clin J Pain; 2012 Feb 26; 28(9):775-81. PubMed ID: 22971669
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Arnold LM, Hirsch I, Sanders P, Ellis A, Hughes B.
    Arthritis Rheum; 2012 Jul 26; 64(7):2387-97. PubMed ID: 22275142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.